nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—ABCB1—ulcerative colitis	0.258	1	CbGaD
Nefazodone—CYP3A4—Budesonide—ulcerative colitis	0.0344	0.0748	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.032	0.0695	CbGbCtD
Nefazodone—CYP3A7—Hydrocortisone—ulcerative colitis	0.032	0.0695	CbGbCtD
Nefazodone—CYP3A5—Sulfasalazine—ulcerative colitis	0.0299	0.0649	CbGbCtD
Nefazodone—ABCB1—Methylprednisolone—ulcerative colitis	0.0257	0.0558	CbGbCtD
Nefazodone—CYP3A5—Hydrocortisone—ulcerative colitis	0.024	0.0521	CbGbCtD
Nefazodone—CYP2D6—Nicotine—ulcerative colitis	0.0236	0.0512	CbGbCtD
Nefazodone—CYP2D6—Cholecalciferol—ulcerative colitis	0.0211	0.0459	CbGbCtD
Nefazodone—CYP3A7—Dexamethasone—ulcerative colitis	0.0199	0.0432	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.0199	0.0432	CbGbCtD
Nefazodone—ABCB1—Betamethasone—ulcerative colitis	0.0167	0.0363	CbGbCtD
Nefazodone—ABCB1—Prednisolone—ulcerative colitis	0.0165	0.0358	CbGbCtD
Nefazodone—ABCB1—Hydrocortisone—ulcerative colitis	0.0156	0.0339	CbGbCtD
Nefazodone—ABCB1—Prednisone—ulcerative colitis	0.0155	0.0338	CbGbCtD
Nefazodone—CYP3A4—Methylprednisolone—ulcerative colitis	0.0154	0.0334	CbGbCtD
Nefazodone—CYP3A4—Nicotine—ulcerative colitis	0.015	0.0326	CbGbCtD
Nefazodone—CYP3A5—Dexamethasone—ulcerative colitis	0.0149	0.0324	CbGbCtD
Nefazodone—CYP3A4—Cholecalciferol—ulcerative colitis	0.0134	0.0292	CbGbCtD
Nefazodone—CYP3A4—Triamcinolone—ulcerative colitis	0.0116	0.0253	CbGbCtD
Nefazodone—CYP3A4—Betamethasone—ulcerative colitis	0.00999	0.0217	CbGbCtD
Nefazodone—CYP3A4—Prednisolone—ulcerative colitis	0.00986	0.0214	CbGbCtD
Nefazodone—ABCB1—Dexamethasone—ulcerative colitis	0.0097	0.0211	CbGbCtD
Nefazodone—CYP3A4—Hydrocortisone—ulcerative colitis	0.00935	0.0203	CbGbCtD
Nefazodone—CYP3A4—Prednisone—ulcerative colitis	0.00931	0.0202	CbGbCtD
Nefazodone—CYP2D6—Dexamethasone—ulcerative colitis	0.00914	0.0199	CbGbCtD
Nefazodone—CYP3A4—Dexamethasone—ulcerative colitis	0.00581	0.0126	CbGbCtD
Nefazodone—HTR2A—enteric nervous system—ulcerative colitis	0.00257	0.32	CbGeAlD
Nefazodone—HTR2A—myenteric nerve plexus—ulcerative colitis	0.00195	0.243	CbGeAlD
Nefazodone—Fluphenazine—CALM3—ulcerative colitis	0.00144	0.288	CrCbGaD
Nefazodone—Trifluoperazine—CALM3—ulcerative colitis	0.00115	0.23	CrCbGaD
Nefazodone—Perphenazine—CALM3—ulcerative colitis	0.00114	0.228	CrCbGaD
Nefazodone—CYP3A7—liver—ulcerative colitis	0.000386	0.048	CbGeAlD
Nefazodone—CYP3A7-CYP3A51P—liver—ulcerative colitis	0.000328	0.0408	CbGeAlD
Nefazodone—ADRA1A—epithelium—ulcerative colitis	0.0003	0.0373	CbGeAlD
Nefazodone—SLC6A4—digestive system—ulcerative colitis	0.000279	0.0347	CbGeAlD
Nefazodone—Domperidone—ABCB1—ulcerative colitis	0.000258	0.0517	CrCbGaD
Nefazodone—ADRA1A—lymphoid tissue—ulcerative colitis	0.000231	0.0288	CbGeAlD
Nefazodone—Aripiprazole—ABCB1—ulcerative colitis	0.000199	0.0399	CrCbGaD
Nefazodone—Trazodone—ABCB1—ulcerative colitis	0.000198	0.0397	CrCbGaD
Nefazodone—Thioproperazine—ALB—ulcerative colitis	0.000198	0.0396	CrCbGaD
Nefazodone—HTR2A—epithelium—ulcerative colitis	0.000194	0.0241	CbGeAlD
Nefazodone—HTR2A—smooth muscle tissue—ulcerative colitis	0.000187	0.0233	CbGeAlD
Nefazodone—CYP3A5—digestive system—ulcerative colitis	0.000182	0.0227	CbGeAlD
Nefazodone—ADRA1A—liver—ulcerative colitis	0.00017	0.0212	CbGeAlD
Nefazodone—Fluphenazine—ABCB1—ulcerative colitis	0.000161	0.0322	CrCbGaD
Nefazodone—HTR2A—digestive system—ulcerative colitis	0.000148	0.0184	CbGeAlD
Nefazodone—CYP3A4—digestive system—ulcerative colitis	0.000137	0.017	CbGeAlD
Nefazodone—CYP3A5—liver—ulcerative colitis	0.000136	0.0169	CbGeAlD
Nefazodone—CYP2D6—digestive system—ulcerative colitis	0.000135	0.0167	CbGeAlD
Nefazodone—Trifluoperazine—ABCB1—ulcerative colitis	0.000128	0.0257	CrCbGaD
Nefazodone—ABCB1—epithelium—ulcerative colitis	0.000127	0.0158	CbGeAlD
Nefazodone—Discomfort—Hydrocortisone—ulcerative colitis	0.000127	0.00057	CcSEcCtD
Nefazodone—Nausea—Budesonide—ulcerative colitis	0.000127	0.000568	CcSEcCtD
Nefazodone—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000126	0.000566	CcSEcCtD
Nefazodone—Oedema—Prednisolone—ulcerative colitis	0.000126	0.000566	CcSEcCtD
Nefazodone—Dizziness—Azathioprine—ulcerative colitis	0.000126	0.000564	CcSEcCtD
Nefazodone—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000125	0.000561	CcSEcCtD
Nefazodone—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000125	0.000559	CcSEcCtD
Nefazodone—Asthenia—Mesalazine—ulcerative colitis	0.000125	0.000558	CcSEcCtD
Nefazodone—Quetiapine—ABCB1—ulcerative colitis	0.000125	0.0249	CrCbGaD
Nefazodone—Shock—Prednisolone—ulcerative colitis	0.000124	0.000557	CcSEcCtD
Nefazodone—Cough—Triamcinolone—ulcerative colitis	0.000124	0.000557	CcSEcCtD
Nefazodone—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000123	0.000553	CcSEcCtD
Nefazodone—Oedema—Hydrocortisone—ulcerative colitis	0.000123	0.000553	CcSEcCtD
Nefazodone—Convulsion—Triamcinolone—ulcerative colitis	0.000123	0.000553	CcSEcCtD
Nefazodone—Tachycardia—Prednisolone—ulcerative colitis	0.000123	0.000552	CcSEcCtD
Nefazodone—Convulsion—Methylprednisolone—ulcerative colitis	0.000123	0.000551	CcSEcCtD
Nefazodone—Hypertension—Triamcinolone—ulcerative colitis	0.000123	0.000551	CcSEcCtD
Nefazodone—Pruritus—Mesalazine—ulcerative colitis	0.000123	0.00055	CcSEcCtD
Nefazodone—Hypertension—Methylprednisolone—ulcerative colitis	0.000123	0.000549	CcSEcCtD
Nefazodone—Infection—Hydrocortisone—ulcerative colitis	0.000123	0.000549	CcSEcCtD
Nefazodone—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000122	0.000547	CcSEcCtD
Nefazodone—Shock—Hydrocortisone—ulcerative colitis	0.000121	0.000544	CcSEcCtD
Nefazodone—Myalgia—Triamcinolone—ulcerative colitis	0.000121	0.000543	CcSEcCtD
Nefazodone—Vomiting—Azathioprine—ulcerative colitis	0.000121	0.000543	CcSEcCtD
Nefazodone—Arthralgia—Methylprednisolone—ulcerative colitis	0.000121	0.000542	CcSEcCtD
Nefazodone—Myalgia—Methylprednisolone—ulcerative colitis	0.000121	0.000542	CcSEcCtD
Nefazodone—Anxiety—Methylprednisolone—ulcerative colitis	0.000121	0.00054	CcSEcCtD
Nefazodone—Tachycardia—Hydrocortisone—ulcerative colitis	0.00012	0.000539	CcSEcCtD
Nefazodone—Rash—Azathioprine—ulcerative colitis	0.00012	0.000538	CcSEcCtD
Nefazodone—Dermatitis—Azathioprine—ulcerative colitis	0.00012	0.000538	CcSEcCtD
Nefazodone—Flushing—Prednisone—ulcerative colitis	0.00012	0.000537	CcSEcCtD
Nefazodone—Ill-defined disorder—Betamethasone—ulcerative colitis	0.00012	0.000537	CcSEcCtD
Nefazodone—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.00012	0.000537	CcSEcCtD
Nefazodone—Discomfort—Triamcinolone—ulcerative colitis	0.00012	0.000536	CcSEcCtD
Nefazodone—Discomfort—Methylprednisolone—ulcerative colitis	0.00012	0.000535	CcSEcCtD
Nefazodone—Headache—Azathioprine—ulcerative colitis	0.000119	0.000535	CcSEcCtD
Nefazodone—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000119	0.000534	CcSEcCtD
Nefazodone—Diarrhoea—Mesalazine—ulcerative colitis	0.000119	0.000532	CcSEcCtD
Nefazodone—Dry mouth—Triamcinolone—ulcerative colitis	0.000119	0.000531	CcSEcCtD
Nefazodone—Angioedema—Dexamethasone—ulcerative colitis	0.000118	0.000529	CcSEcCtD
Nefazodone—Angioedema—Betamethasone—ulcerative colitis	0.000118	0.000529	CcSEcCtD
Nefazodone—Anorexia—Hydrocortisone—ulcerative colitis	0.000118	0.000527	CcSEcCtD
Nefazodone—Confusional state—Methylprednisolone—ulcerative colitis	0.000117	0.000524	CcSEcCtD
Nefazodone—Malaise—Dexamethasone—ulcerative colitis	0.000117	0.000522	CcSEcCtD
Nefazodone—Malaise—Betamethasone—ulcerative colitis	0.000117	0.000522	CcSEcCtD
Nefazodone—Oedema—Triamcinolone—ulcerative colitis	0.000116	0.00052	CcSEcCtD
Nefazodone—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000116	0.00052	CcSEcCtD
Nefazodone—Vertigo—Betamethasone—ulcerative colitis	0.000116	0.00052	CcSEcCtD
Nefazodone—Vertigo—Dexamethasone—ulcerative colitis	0.000116	0.00052	CcSEcCtD
Nefazodone—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000116	0.000519	CcSEcCtD
Nefazodone—Syncope—Dexamethasone—ulcerative colitis	0.000116	0.000519	CcSEcCtD
Nefazodone—Syncope—Betamethasone—ulcerative colitis	0.000116	0.000519	CcSEcCtD
Nefazodone—Infection—Triamcinolone—ulcerative colitis	0.000115	0.000517	CcSEcCtD
Nefazodone—Hypotension—Hydrocortisone—ulcerative colitis	0.000115	0.000517	CcSEcCtD
Nefazodone—Infection—Methylprednisolone—ulcerative colitis	0.000115	0.000516	CcSEcCtD
Nefazodone—Dizziness—Mesalazine—ulcerative colitis	0.000115	0.000514	CcSEcCtD
Nefazodone—Shock—Triamcinolone—ulcerative colitis	0.000114	0.000512	CcSEcCtD
Nefazodone—Insomnia—Prednisolone—ulcerative colitis	0.000114	0.000512	CcSEcCtD
Nefazodone—Alopecia—Prednisone—ulcerative colitis	0.000114	0.000512	CcSEcCtD
Nefazodone—Shock—Methylprednisolone—ulcerative colitis	0.000114	0.000511	CcSEcCtD
Nefazodone—Loss of consciousness—Betamethasone—ulcerative colitis	0.000114	0.000509	CcSEcCtD
Nefazodone—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000114	0.000509	CcSEcCtD
Nefazodone—Paraesthesia—Prednisolone—ulcerative colitis	0.000113	0.000508	CcSEcCtD
Nefazodone—Tachycardia—Triamcinolone—ulcerative colitis	0.000113	0.000508	CcSEcCtD
Nefazodone—Nausea—Azathioprine—ulcerative colitis	0.000113	0.000507	CcSEcCtD
Nefazodone—Tachycardia—Methylprednisolone—ulcerative colitis	0.000113	0.000507	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000112	0.000504	CcSEcCtD
Nefazodone—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000112	0.000503	CcSEcCtD
Nefazodone—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000112	0.000502	CcSEcCtD
Nefazodone—Convulsion—Betamethasone—ulcerative colitis	0.000112	0.000501	CcSEcCtD
Nefazodone—Convulsion—Dexamethasone—ulcerative colitis	0.000112	0.000501	CcSEcCtD
Nefazodone—Insomnia—Hydrocortisone—ulcerative colitis	0.000112	0.0005	CcSEcCtD
Nefazodone—Hypertension—Betamethasone—ulcerative colitis	0.000112	0.0005	CcSEcCtD
Nefazodone—Hypertension—Dexamethasone—ulcerative colitis	0.000112	0.0005	CcSEcCtD
Nefazodone—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000111	0.000496	CcSEcCtD
Nefazodone—Vomiting—Mesalazine—ulcerative colitis	0.00011	0.000494	CcSEcCtD
Nefazodone—HTR2A—liver—ulcerative colitis	0.00011	0.0137	CbGeAlD
Nefazodone—Myalgia—Betamethasone—ulcerative colitis	0.00011	0.000493	CcSEcCtD
Nefazodone—Myalgia—Dexamethasone—ulcerative colitis	0.00011	0.000493	CcSEcCtD
Nefazodone—Anxiety—Betamethasone—ulcerative colitis	0.00011	0.000491	CcSEcCtD
Nefazodone—Anxiety—Dexamethasone—ulcerative colitis	0.00011	0.000491	CcSEcCtD
Nefazodone—Rash—Mesalazine—ulcerative colitis	0.000109	0.00049	CcSEcCtD
Nefazodone—Dermatitis—Mesalazine—ulcerative colitis	0.000109	0.00049	CcSEcCtD
Nefazodone—Headache—Mesalazine—ulcerative colitis	0.000109	0.000487	CcSEcCtD
Nefazodone—Discomfort—Dexamethasone—ulcerative colitis	0.000109	0.000487	CcSEcCtD
Nefazodone—Discomfort—Betamethasone—ulcerative colitis	0.000109	0.000487	CcSEcCtD
Nefazodone—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000109	0.000487	CcSEcCtD
Nefazodone—Hypotension—Methylprednisolone—ulcerative colitis	0.000108	0.000485	CcSEcCtD
Nefazodone—Pain—Prednisolone—ulcerative colitis	0.000108	0.000484	CcSEcCtD
Nefazodone—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000107	0.000481	CcSEcCtD
Nefazodone—Vision blurred—Prednisone—ulcerative colitis	0.000106	0.000475	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000106	0.000474	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000106	0.000473	CcSEcCtD
Nefazodone—Pain—Hydrocortisone—ulcerative colitis	0.000106	0.000473	CcSEcCtD
Nefazodone—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000105	0.000472	CcSEcCtD
Nefazodone—Oedema—Betamethasone—ulcerative colitis	0.000105	0.000472	CcSEcCtD
Nefazodone—Oedema—Dexamethasone—ulcerative colitis	0.000105	0.000472	CcSEcCtD
Nefazodone—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000105	0.000472	CcSEcCtD
Nefazodone—Insomnia—Triamcinolone—ulcerative colitis	0.000105	0.000471	CcSEcCtD
Nefazodone—Insomnia—Methylprednisolone—ulcerative colitis	0.000105	0.00047	CcSEcCtD
Nefazodone—Infection—Dexamethasone—ulcerative colitis	0.000105	0.000469	CcSEcCtD
Nefazodone—Infection—Betamethasone—ulcerative colitis	0.000105	0.000469	CcSEcCtD
Nefazodone—Ill-defined disorder—Prednisone—ulcerative colitis	0.000104	0.000468	CcSEcCtD
Nefazodone—Paraesthesia—Triamcinolone—ulcerative colitis	0.000104	0.000467	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisolone—ulcerative colitis	0.000104	0.000466	CcSEcCtD
Nefazodone—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000104	0.000466	CcSEcCtD
Nefazodone—Anaemia—Prednisone—ulcerative colitis	0.000104	0.000466	CcSEcCtD
Nefazodone—Shock—Betamethasone—ulcerative colitis	0.000104	0.000465	CcSEcCtD
Nefazodone—Shock—Dexamethasone—ulcerative colitis	0.000104	0.000465	CcSEcCtD
Nefazodone—Dyspnoea—Triamcinolone—ulcerative colitis	0.000104	0.000464	CcSEcCtD
Nefazodone—Agitation—Prednisone—ulcerative colitis	0.000103	0.000463	CcSEcCtD
Nefazodone—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000103	0.000462	CcSEcCtD
Nefazodone—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000103	0.000462	CcSEcCtD
Nefazodone—Nausea—Mesalazine—ulcerative colitis	0.000103	0.000462	CcSEcCtD
Nefazodone—Tachycardia—Betamethasone—ulcerative colitis	0.000103	0.000461	CcSEcCtD
Nefazodone—Tachycardia—Dexamethasone—ulcerative colitis	0.000103	0.000461	CcSEcCtD
Nefazodone—Angioedema—Prednisone—ulcerative colitis	0.000103	0.00046	CcSEcCtD
Nefazodone—Dyspepsia—Triamcinolone—ulcerative colitis	0.000102	0.000458	CcSEcCtD
Nefazodone—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000102	0.000457	CcSEcCtD
Nefazodone—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000102	0.000457	CcSEcCtD
Nefazodone—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000102	0.000457	CcSEcCtD
Nefazodone—CYP3A4—liver—ulcerative colitis	0.000102	0.0127	CbGeAlD
Nefazodone—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000102	0.000456	CcSEcCtD
Nefazodone—Malaise—Prednisone—ulcerative colitis	0.000101	0.000454	CcSEcCtD
Nefazodone—Vertigo—Prednisone—ulcerative colitis	0.000101	0.000453	CcSEcCtD
Nefazodone—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000101	0.000452	CcSEcCtD
Nefazodone—Syncope—Prednisone—ulcerative colitis	0.000101	0.000452	CcSEcCtD
Nefazodone—Anorexia—Dexamethasone—ulcerative colitis	0.000101	0.00045	CcSEcCtD
Nefazodone—Anorexia—Betamethasone—ulcerative colitis	0.000101	0.00045	CcSEcCtD
Nefazodone—Urticaria—Prednisolone—ulcerative colitis	0.0001	0.00045	CcSEcCtD
Nefazodone—CYP2D6—liver—ulcerative colitis	0.0001	0.0125	CbGeAlD
Nefazodone—Pain—Triamcinolone—ulcerative colitis	9.94e-05	0.000445	CcSEcCtD
Nefazodone—Loss of consciousness—Prednisone—ulcerative colitis	9.89e-05	0.000443	CcSEcCtD
Nefazodone—Hypotension—Betamethasone—ulcerative colitis	9.85e-05	0.000441	CcSEcCtD
Nefazodone—Hypotension—Dexamethasone—ulcerative colitis	9.85e-05	0.000441	CcSEcCtD
Nefazodone—Urticaria—Hydrocortisone—ulcerative colitis	9.81e-05	0.000439	CcSEcCtD
Nefazodone—ABCB1—lymphoid tissue—ulcerative colitis	9.8e-05	0.0122	CbGeAlD
Nefazodone—Abdominal pain—Hydrocortisone—ulcerative colitis	9.76e-05	0.000437	CcSEcCtD
Nefazodone—Body temperature increased—Hydrocortisone—ulcerative colitis	9.76e-05	0.000437	CcSEcCtD
Nefazodone—Convulsion—Prednisone—ulcerative colitis	9.75e-05	0.000437	CcSEcCtD
Nefazodone—Hypertension—Prednisone—ulcerative colitis	9.72e-05	0.000435	CcSEcCtD
Nefazodone—ABCB1—digestive system—ulcerative colitis	9.68e-05	0.012	CbGeAlD
Nefazodone—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	9.61e-05	0.00043	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	9.61e-05	0.00043	CcSEcCtD
Nefazodone—Arthralgia—Prednisone—ulcerative colitis	9.58e-05	0.000429	CcSEcCtD
Nefazodone—Myalgia—Prednisone—ulcerative colitis	9.58e-05	0.000429	CcSEcCtD
Nefazodone—Feeling abnormal—Triamcinolone—ulcerative colitis	9.58e-05	0.000429	CcSEcCtD
Nefazodone—Feeling abnormal—Methylprednisolone—ulcerative colitis	9.56e-05	0.000428	CcSEcCtD
Nefazodone—Anxiety—Prednisone—ulcerative colitis	9.55e-05	0.000428	CcSEcCtD
Nefazodone—Insomnia—Dexamethasone—ulcerative colitis	9.54e-05	0.000427	CcSEcCtD
Nefazodone—Insomnia—Betamethasone—ulcerative colitis	9.54e-05	0.000427	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	9.48e-05	0.000425	CcSEcCtD
Nefazodone—Paraesthesia—Betamethasone—ulcerative colitis	9.47e-05	0.000424	CcSEcCtD
Nefazodone—Paraesthesia—Dexamethasone—ulcerative colitis	9.47e-05	0.000424	CcSEcCtD
Nefazodone—Discomfort—Prednisone—ulcerative colitis	9.47e-05	0.000424	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisolone—ulcerative colitis	9.31e-05	0.000417	CcSEcCtD
Nefazodone—Dyspepsia—Dexamethasone—ulcerative colitis	9.28e-05	0.000416	CcSEcCtD
Nefazodone—Dyspepsia—Betamethasone—ulcerative colitis	9.28e-05	0.000416	CcSEcCtD
Nefazodone—Urticaria—Triamcinolone—ulcerative colitis	9.23e-05	0.000413	CcSEcCtD
Nefazodone—Urticaria—Methylprednisolone—ulcerative colitis	9.21e-05	0.000413	CcSEcCtD
Nefazodone—Body temperature increased—Triamcinolone—ulcerative colitis	9.19e-05	0.000411	CcSEcCtD
Nefazodone—Anaphylactic shock—Prednisone—ulcerative colitis	9.18e-05	0.000411	CcSEcCtD
Nefazodone—Oedema—Prednisone—ulcerative colitis	9.18e-05	0.000411	CcSEcCtD
Nefazodone—Abdominal pain—Methylprednisolone—ulcerative colitis	9.17e-05	0.000411	CcSEcCtD
Nefazodone—Decreased appetite—Dexamethasone—ulcerative colitis	9.17e-05	0.000411	CcSEcCtD
Nefazodone—Decreased appetite—Betamethasone—ulcerative colitis	9.17e-05	0.000411	CcSEcCtD
Nefazodone—Infection—Prednisone—ulcerative colitis	9.12e-05	0.000409	CcSEcCtD
Nefazodone—Hypersensitivity—Hydrocortisone—ulcerative colitis	9.09e-05	0.000407	CcSEcCtD
Nefazodone—Shock—Prednisone—ulcerative colitis	9.04e-05	0.000405	CcSEcCtD
Nefazodone—Pain—Dexamethasone—ulcerative colitis	9.02e-05	0.000404	CcSEcCtD
Nefazodone—Pain—Betamethasone—ulcerative colitis	9.02e-05	0.000404	CcSEcCtD
Nefazodone—Tachycardia—Prednisone—ulcerative colitis	8.96e-05	0.000401	CcSEcCtD
Nefazodone—Hyperhidrosis—Prednisone—ulcerative colitis	8.88e-05	0.000398	CcSEcCtD
Nefazodone—Asthenia—Hydrocortisone—ulcerative colitis	8.86e-05	0.000397	CcSEcCtD
Nefazodone—Anorexia—Prednisone—ulcerative colitis	8.75e-05	0.000392	CcSEcCtD
Nefazodone—Pruritus—Hydrocortisone—ulcerative colitis	8.73e-05	0.000391	CcSEcCtD
Nefazodone—Feeling abnormal—Betamethasone—ulcerative colitis	8.69e-05	0.000389	CcSEcCtD
Nefazodone—Feeling abnormal—Dexamethasone—ulcerative colitis	8.69e-05	0.000389	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dexamethasone—ulcerative colitis	8.62e-05	0.000386	CcSEcCtD
Nefazodone—Gastrointestinal pain—Betamethasone—ulcerative colitis	8.62e-05	0.000386	CcSEcCtD
Nefazodone—Hypersensitivity—Triamcinolone—ulcerative colitis	8.56e-05	0.000383	CcSEcCtD
Nefazodone—Hypersensitivity—Methylprednisolone—ulcerative colitis	8.54e-05	0.000383	CcSEcCtD
Nefazodone—Diarrhoea—Hydrocortisone—ulcerative colitis	8.45e-05	0.000378	CcSEcCtD
Nefazodone—Urticaria—Dexamethasone—ulcerative colitis	8.38e-05	0.000375	CcSEcCtD
Nefazodone—Urticaria—Betamethasone—ulcerative colitis	8.38e-05	0.000375	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Prednisone—ulcerative colitis	8.37e-05	0.000375	CcSEcCtD
Nefazodone—Dizziness—Prednisolone—ulcerative colitis	8.36e-05	0.000374	CcSEcCtD
Nefazodone—Asthenia—Triamcinolone—ulcerative colitis	8.34e-05	0.000373	CcSEcCtD
Nefazodone—Abdominal pain—Betamethasone—ulcerative colitis	8.34e-05	0.000373	CcSEcCtD
Nefazodone—Body temperature increased—Dexamethasone—ulcerative colitis	8.34e-05	0.000373	CcSEcCtD
Nefazodone—Abdominal pain—Dexamethasone—ulcerative colitis	8.34e-05	0.000373	CcSEcCtD
Nefazodone—Body temperature increased—Betamethasone—ulcerative colitis	8.34e-05	0.000373	CcSEcCtD
Nefazodone—Asthenia—Methylprednisolone—ulcerative colitis	8.32e-05	0.000373	CcSEcCtD
Nefazodone—Insomnia—Prednisone—ulcerative colitis	8.31e-05	0.000372	CcSEcCtD
Nefazodone—Paraesthesia—Prednisone—ulcerative colitis	8.25e-05	0.000369	CcSEcCtD
Nefazodone—Pruritus—Triamcinolone—ulcerative colitis	8.22e-05	0.000368	CcSEcCtD
Nefazodone—Pruritus—Methylprednisolone—ulcerative colitis	8.2e-05	0.000367	CcSEcCtD
Nefazodone—Dizziness—Hydrocortisone—ulcerative colitis	8.16e-05	0.000366	CcSEcCtD
Nefazodone—Dyspepsia—Prednisone—ulcerative colitis	8.08e-05	0.000362	CcSEcCtD
Nefazodone—Decreased appetite—Prednisone—ulcerative colitis	7.98e-05	0.000358	CcSEcCtD
Nefazodone—Rash—Prednisolone—ulcerative colitis	7.97e-05	0.000357	CcSEcCtD
Nefazodone—Dermatitis—Prednisolone—ulcerative colitis	7.96e-05	0.000357	CcSEcCtD
Nefazodone—Diarrhoea—Methylprednisolone—ulcerative colitis	7.93e-05	0.000355	CcSEcCtD
Nefazodone—Headache—Prednisolone—ulcerative colitis	7.92e-05	0.000355	CcSEcCtD
Nefazodone—Constipation—Prednisone—ulcerative colitis	7.85e-05	0.000352	CcSEcCtD
Nefazodone—Vomiting—Hydrocortisone—ulcerative colitis	7.85e-05	0.000351	CcSEcCtD
Nefazodone—Rash—Hydrocortisone—ulcerative colitis	7.78e-05	0.000349	CcSEcCtD
Nefazodone—Dermatitis—Hydrocortisone—ulcerative colitis	7.78e-05	0.000348	CcSEcCtD
Nefazodone—Headache—Hydrocortisone—ulcerative colitis	7.73e-05	0.000346	CcSEcCtD
Nefazodone—Dizziness—Triamcinolone—ulcerative colitis	7.69e-05	0.000344	CcSEcCtD
Nefazodone—Dizziness—Methylprednisolone—ulcerative colitis	7.67e-05	0.000343	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisone—ulcerative colitis	7.57e-05	0.000339	CcSEcCtD
Nefazodone—Asthenia—Betamethasone—ulcerative colitis	7.57e-05	0.000339	CcSEcCtD
Nefazodone—Asthenia—Dexamethasone—ulcerative colitis	7.57e-05	0.000339	CcSEcCtD
Nefazodone—Gastrointestinal pain—Prednisone—ulcerative colitis	7.51e-05	0.000336	CcSEcCtD
Nefazodone—Nausea—Prednisolone—ulcerative colitis	7.51e-05	0.000336	CcSEcCtD
Nefazodone—Pruritus—Dexamethasone—ulcerative colitis	7.46e-05	0.000334	CcSEcCtD
Nefazodone—Pruritus—Betamethasone—ulcerative colitis	7.46e-05	0.000334	CcSEcCtD
Nefazodone—Vomiting—Triamcinolone—ulcerative colitis	7.39e-05	0.000331	CcSEcCtD
Nefazodone—Vomiting—Methylprednisolone—ulcerative colitis	7.37e-05	0.00033	CcSEcCtD
Nefazodone—Nausea—Hydrocortisone—ulcerative colitis	7.33e-05	0.000328	CcSEcCtD
Nefazodone—Rash—Triamcinolone—ulcerative colitis	7.33e-05	0.000328	CcSEcCtD
Nefazodone—Dermatitis—Triamcinolone—ulcerative colitis	7.32e-05	0.000328	CcSEcCtD
Nefazodone—Rash—Methylprednisolone—ulcerative colitis	7.31e-05	0.000327	CcSEcCtD
Nefazodone—Dermatitis—Methylprednisolone—ulcerative colitis	7.31e-05	0.000327	CcSEcCtD
Nefazodone—Urticaria—Prednisone—ulcerative colitis	7.3e-05	0.000327	CcSEcCtD
Nefazodone—Headache—Triamcinolone—ulcerative colitis	7.28e-05	0.000326	CcSEcCtD
Nefazodone—Headache—Methylprednisolone—ulcerative colitis	7.26e-05	0.000325	CcSEcCtD
Nefazodone—Abdominal pain—Prednisone—ulcerative colitis	7.26e-05	0.000325	CcSEcCtD
Nefazodone—Body temperature increased—Prednisone—ulcerative colitis	7.26e-05	0.000325	CcSEcCtD
Nefazodone—Diarrhoea—Dexamethasone—ulcerative colitis	7.22e-05	0.000323	CcSEcCtD
Nefazodone—Diarrhoea—Betamethasone—ulcerative colitis	7.22e-05	0.000323	CcSEcCtD
Nefazodone—ABCB1—liver—ulcerative colitis	7.21e-05	0.00897	CbGeAlD
Nefazodone—Dizziness—Dexamethasone—ulcerative colitis	6.97e-05	0.000312	CcSEcCtD
Nefazodone—Dizziness—Betamethasone—ulcerative colitis	6.97e-05	0.000312	CcSEcCtD
Nefazodone—Nausea—Triamcinolone—ulcerative colitis	6.9e-05	0.000309	CcSEcCtD
Nefazodone—Nausea—Methylprednisolone—ulcerative colitis	6.89e-05	0.000308	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisone—ulcerative colitis	6.77e-05	0.000303	CcSEcCtD
Nefazodone—Vomiting—Dexamethasone—ulcerative colitis	6.71e-05	0.0003	CcSEcCtD
Nefazodone—Vomiting—Betamethasone—ulcerative colitis	6.71e-05	0.0003	CcSEcCtD
Nefazodone—Rash—Betamethasone—ulcerative colitis	6.65e-05	0.000298	CcSEcCtD
Nefazodone—Rash—Dexamethasone—ulcerative colitis	6.65e-05	0.000298	CcSEcCtD
Nefazodone—Dermatitis—Betamethasone—ulcerative colitis	6.64e-05	0.000298	CcSEcCtD
Nefazodone—Dermatitis—Dexamethasone—ulcerative colitis	6.64e-05	0.000298	CcSEcCtD
Nefazodone—Headache—Betamethasone—ulcerative colitis	6.61e-05	0.000296	CcSEcCtD
Nefazodone—Headache—Dexamethasone—ulcerative colitis	6.61e-05	0.000296	CcSEcCtD
Nefazodone—Asthenia—Prednisone—ulcerative colitis	6.59e-05	0.000295	CcSEcCtD
Nefazodone—Pruritus—Prednisone—ulcerative colitis	6.5e-05	0.000291	CcSEcCtD
Nefazodone—Diarrhoea—Prednisone—ulcerative colitis	6.28e-05	0.000281	CcSEcCtD
Nefazodone—Nausea—Dexamethasone—ulcerative colitis	6.26e-05	0.000281	CcSEcCtD
Nefazodone—Nausea—Betamethasone—ulcerative colitis	6.26e-05	0.000281	CcSEcCtD
Nefazodone—Dizziness—Prednisone—ulcerative colitis	6.07e-05	0.000272	CcSEcCtD
Nefazodone—Vomiting—Prednisone—ulcerative colitis	5.84e-05	0.000262	CcSEcCtD
Nefazodone—Rash—Prednisone—ulcerative colitis	5.79e-05	0.000259	CcSEcCtD
Nefazodone—Dermatitis—Prednisone—ulcerative colitis	5.79e-05	0.000259	CcSEcCtD
Nefazodone—Headache—Prednisone—ulcerative colitis	5.75e-05	0.000258	CcSEcCtD
Nefazodone—Nausea—Prednisone—ulcerative colitis	5.46e-05	0.000244	CcSEcCtD
Nefazodone—ADRA1B—Signaling by GPCR—ADRB2—ulcerative colitis	1.92e-05	0.000419	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—ADRB2—ulcerative colitis	1.91e-05	0.000418	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—GHRL—ulcerative colitis	1.91e-05	0.000418	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—GNA12—ulcerative colitis	1.9e-05	0.000416	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCR1—ulcerative colitis	1.9e-05	0.000416	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCR2—ulcerative colitis	1.89e-05	0.000414	CbGpPWpGaD
Nefazodone—HTR1A—GPCR ligand binding—CXCL8—ulcerative colitis	1.89e-05	0.000414	CbGpPWpGaD
Nefazodone—SLC6A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.89e-05	0.000413	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCR2—ulcerative colitis	1.88e-05	0.000412	CbGpPWpGaD
Nefazodone—HTR2C—GPCR ligand binding—CXCL8—ulcerative colitis	1.88e-05	0.000412	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.88e-05	0.000411	CbGpPWpGaD
Nefazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.88e-05	0.00041	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—ADRB2—ulcerative colitis	1.87e-05	0.00041	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—ADCY5—ulcerative colitis	1.87e-05	0.000409	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CALM3—ulcerative colitis	1.85e-05	0.000404	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS1—ulcerative colitis	1.84e-05	0.000402	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL20—ulcerative colitis	1.84e-05	0.000401	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCR2—ulcerative colitis	1.8e-05	0.000394	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR ligand binding—CXCL8—ulcerative colitis	1.8e-05	0.000394	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL20—ulcerative colitis	1.8e-05	0.000393	CbGpPWpGaD
Nefazodone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.8e-05	0.000393	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.79e-05	0.000392	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—ADCY5—ulcerative colitis	1.79e-05	0.000391	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCR6—ulcerative colitis	1.78e-05	0.000389	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCR6—ulcerative colitis	1.77e-05	0.000387	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—ADRB2—ulcerative colitis	1.74e-05	0.000381	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—ADRB2—ulcerative colitis	1.74e-05	0.00038	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—GNA12—ulcerative colitis	1.73e-05	0.000377	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—ADCY5—ulcerative colitis	1.71e-05	0.000373	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	1.7e-05	0.000372	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—ADCY5—ulcerative colitis	1.7e-05	0.000371	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCR6—ulcerative colitis	1.7e-05	0.000371	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	1.69e-05	0.000369	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MAML2—ulcerative colitis	1.69e-05	0.000369	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MAML2—ulcerative colitis	1.68e-05	0.000367	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL20—ulcerative colitis	1.67e-05	0.000365	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—CALM3—ulcerative colitis	1.66e-05	0.000362	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCR2—ulcerative colitis	1.64e-05	0.000358	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—CXCL8—ulcerative colitis	1.64e-05	0.000357	CbGpPWpGaD
Nefazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.63e-05	0.000356	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—ADCY5—ulcerative colitis	1.63e-05	0.000355	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.62e-05	0.000355	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MAML2—ulcerative colitis	1.61e-05	0.000351	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	1.6e-05	0.00035	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	1.6e-05	0.00035	CbGpPWpGaD
Nefazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.6e-05	0.000349	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.59e-05	0.000348	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—ADRB2—ulcerative colitis	1.58e-05	0.000346	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—GNA12—ulcerative colitis	1.57e-05	0.000343	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—ALB—ulcerative colitis	1.57e-05	0.000343	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PTGER4—ulcerative colitis	1.57e-05	0.000343	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PTGER4—ulcerative colitis	1.56e-05	0.000341	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCR6—ulcerative colitis	1.54e-05	0.000336	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	1.51e-05	0.000329	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.5e-05	0.000327	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PTGER4—ulcerative colitis	1.49e-05	0.000326	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCR2—ulcerative colitis	1.49e-05	0.000325	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—CXCL8—ulcerative colitis	1.49e-05	0.000325	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.48e-05	0.000324	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.48e-05	0.000323	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—ADCY5—ulcerative colitis	1.47e-05	0.000322	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MAML2—ulcerative colitis	1.46e-05	0.000319	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—JAK2—ulcerative colitis	1.46e-05	0.000319	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS1—ulcerative colitis	1.45e-05	0.000317	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	1.44e-05	0.000316	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—GHRL—ulcerative colitis	1.44e-05	0.000314	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	1.43e-05	0.000312	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—GHRL—ulcerative colitis	1.43e-05	0.000312	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCR6—ulcerative colitis	1.4e-05	0.000306	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.4e-05	0.000306	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.4e-05	0.000305	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CALM3—ulcerative colitis	1.39e-05	0.000304	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CALM3—ulcerative colitis	1.38e-05	0.000302	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RIPK2—ulcerative colitis	1.37e-05	0.000299	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—GHRL—ulcerative colitis	1.37e-05	0.000299	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RIPK2—ulcerative colitis	1.36e-05	0.000298	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PTGER4—ulcerative colitis	1.35e-05	0.000296	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—ADCY5—ulcerative colitis	1.34e-05	0.000293	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS1—ulcerative colitis	1.33e-05	0.000291	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MAML2—ulcerative colitis	1.33e-05	0.00029	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	1.33e-05	0.00029	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CALM3—ulcerative colitis	1.32e-05	0.000289	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CALM3—ulcerative colitis	1.31e-05	0.000286	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RIPK2—ulcerative colitis	1.3e-05	0.000285	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ABCB1—ulcerative colitis	1.29e-05	0.000282	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—DLD—ulcerative colitis	1.28e-05	0.00028	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—IL2—ulcerative colitis	1.27e-05	0.000278	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—GHRL—ulcerative colitis	1.24e-05	0.000271	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PTGER4—ulcerative colitis	1.23e-05	0.000269	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.23e-05	0.000269	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	1.21e-05	0.000265	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ADCY5—ulcerative colitis	1.2e-05	0.000263	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CALM3—ulcerative colitis	1.2e-05	0.000263	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CALM3—ulcerative colitis	1.2e-05	0.000262	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—ADRB2—ulcerative colitis	1.19e-05	0.00026	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RIPK2—ulcerative colitis	1.18e-05	0.000259	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—ADRB2—ulcerative colitis	1.18e-05	0.000258	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	1.18e-05	0.000257	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—JAK2—ulcerative colitis	1.17e-05	0.000256	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—JAK2—ulcerative colitis	1.17e-05	0.000255	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	1.16e-05	0.000253	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	1.13e-05	0.000247	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	1.13e-05	0.000247	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	1.12e-05	0.000244	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	1.09e-05	0.000239	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	1.08e-05	0.000235	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.07e-05	0.000234	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—JAK2—ulcerative colitis	1.06e-05	0.000233	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—CXCL8—ulcerative colitis	1.06e-05	0.000233	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—JAK2—ulcerative colitis	1.06e-05	0.000231	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ADRB2—ulcerative colitis	1.03e-05	0.000224	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—IL2—ulcerative colitis	1.02e-05	0.000223	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	1.02e-05	0.000223	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—IL2—ulcerative colitis	1.02e-05	0.000222	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ABCB1—ulcerative colitis	1.02e-05	0.000222	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	1.01e-05	0.000222	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—JAK2—ulcerative colitis	1.01e-05	0.000221	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—ADCY5—ulcerative colitis	1.01e-05	0.00022	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	1.01e-05	0.00022	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS1—ulcerative colitis	1e-05	0.000219	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—ADCY5—ulcerative colitis	1e-05	0.000219	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	9.92e-06	0.000217	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	9.91e-06	0.000217	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	9.74e-06	0.000213	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—CXCL8—ulcerative colitis	9.71e-06	0.000212	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—CXCL8—ulcerative colitis	9.66e-06	0.000211	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	9.6e-06	0.00021	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ADCY5—ulcerative colitis	9.48e-06	0.000207	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS1—ulcerative colitis	9.46e-06	0.000207	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.39e-06	0.000205	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	9.34e-06	0.000204	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ABCB1—ulcerative colitis	9.31e-06	0.000204	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL2—ulcerative colitis	9.28e-06	0.000203	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	9.25e-06	0.000202	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CXCL8—ulcerative colitis	9.24e-06	0.000202	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL2—ulcerative colitis	9.24e-06	0.000202	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	9.21e-06	0.000201	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—JAK2—ulcerative colitis	9.19e-06	0.000201	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	9.05e-06	0.000198	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CALM3—ulcerative colitis	9.04e-06	0.000198	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	9e-06	0.000197	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PPARG—ulcerative colitis	8.96e-06	0.000196	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	8.84e-06	0.000193	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2—ulcerative colitis	8.83e-06	0.000193	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ADCY5—ulcerative colitis	8.71e-06	0.00019	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ADCY5—ulcerative colitis	8.69e-06	0.00019	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	8.65e-06	0.000189	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	8.53e-06	0.000187	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CALM3—ulcerative colitis	8.51e-06	0.000186	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	8.41e-06	0.000184	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CXCL8—ulcerative colitis	8.39e-06	0.000183	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	8.36e-06	0.000183	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	8.22e-06	0.00018	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TP53—ulcerative colitis	8.16e-06	0.000178	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALB—ulcerative colitis	8.06e-06	0.000176	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	8.03e-06	0.000176	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	8.02e-06	0.000175	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	7.93e-06	0.000173	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	7.85e-06	0.000172	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	7.63e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	7.3e-06	0.00016	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PPARG—ulcerative colitis	7.07e-06	0.000155	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS2—ulcerative colitis	7.05e-06	0.000154	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ABCB1—ulcerative colitis	6.62e-06	0.000145	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ADCY5—ulcerative colitis	6.55e-06	0.000143	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PPARG—ulcerative colitis	6.48e-06	0.000142	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—ulcerative colitis	6.36e-06	0.000139	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—JAK2—ulcerative colitis	6.29e-06	0.000137	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—JAK2—ulcerative colitis	6.25e-06	0.000137	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS1—ulcerative colitis	6.18e-06	0.000135	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ADCY5—ulcerative colitis	6.18e-06	0.000135	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RELA—ulcerative colitis	6.09e-06	0.000133	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RELA—ulcerative colitis	6.06e-06	0.000132	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	5.99e-06	0.000131	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—ulcerative colitis	5.83e-06	0.000127	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	5.8e-06	0.000127	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCL8—ulcerative colitis	5.74e-06	0.000125	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCL8—ulcerative colitis	5.71e-06	0.000125	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CALM3—ulcerative colitis	5.57e-06	0.000122	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—ulcerative colitis	5.56e-06	0.000122	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2—ulcerative colitis	5.48e-06	0.00012	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	5.46e-06	0.000119	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—ulcerative colitis	5.46e-06	0.000119	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2—ulcerative colitis	5.46e-06	0.000119	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	5.43e-06	0.000119	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—ulcerative colitis	5.43e-06	0.000119	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	5.32e-06	0.000116	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RELA—ulcerative colitis	5.26e-06	0.000115	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	5.22e-06	0.000114	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	5.2e-06	0.000114	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MMP9—ulcerative colitis	5.19e-06	0.000113	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MMP9—ulcerative colitis	5.16e-06	0.000113	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	5.15e-06	0.000113	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NFKB1—ulcerative colitis	5.14e-06	0.000112	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NFKB1—ulcerative colitis	5.11e-06	0.000112	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—ulcerative colitis	5.1e-06	0.000111	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	4.96e-06	0.000108	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	4.94e-06	0.000108	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	4.94e-06	0.000108	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	4.89e-06	0.000107	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PPARG—ulcerative colitis	4.89e-06	0.000107	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	4.85e-06	0.000106	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	4.79e-06	0.000105	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2—ulcerative colitis	4.74e-06	0.000104	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	4.71e-06	0.000103	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	4.64e-06	0.000101	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	4.62e-06	0.000101	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—STAT3—ulcerative colitis	4.61e-06	0.000101	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PPARG—ulcerative colitis	4.61e-06	0.000101	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—STAT3—ulcerative colitis	4.59e-06	0.0001	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	4.51e-06	9.86e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	4.48e-06	9.8e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	4.44e-06	9.7e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—ulcerative colitis	4.4e-06	9.61e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	4.39e-06	9.61e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	4.39e-06	9.6e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	4.34e-06	9.5e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.33e-06	9.46e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	4.31e-06	9.42e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	4.29e-06	9.38e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TGFB1—ulcerative colitis	4.28e-06	9.35e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TGFB1—ulcerative colitis	4.26e-06	9.3e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—ulcerative colitis	4.14e-06	9.06e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	4.08e-06	8.92e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	4.07e-06	8.91e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.04e-06	8.83e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	4.04e-06	8.82e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	3.99e-06	8.72e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	3.9e-06	8.53e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.85e-06	8.41e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	3.7e-06	8.08e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	3.63e-06	7.93e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—ulcerative colitis	3.62e-06	7.92e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	3.62e-06	7.91e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TP53—ulcerative colitis	3.52e-06	7.7e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TP53—ulcerative colitis	3.5e-06	7.66e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	3.36e-06	7.35e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	3.35e-06	7.33e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—ulcerative colitis	3.22e-06	7.05e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—ulcerative colitis	3.21e-06	7.01e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	3.07e-06	6.71e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TP53—ulcerative colitis	3.04e-06	6.65e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.01e-06	6.58e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	2.98e-06	6.51e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—ulcerative colitis	2.78e-06	6.09e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	2.77e-06	6.05e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	2.73e-06	5.96e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—ulcerative colitis	2.71e-06	5.92e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	2.53e-06	5.54e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.37e-06	5.18e-05	CbGpPWpGaD
